Abalos Therapeutics is a biotechnology company that develops drugs for tumors and cancer. Read more

Abalos Therapeutics is a biotechnology company that develops drugs for tumors and cancer. Read more

Marcus Kostka's photo - CEO of Abalos Therapeutics

CEO

Marcus Kostka

CEO Approval Rating

90/100

Founded:

2019

Status:

PrivateIndependent Company

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Agenus is one of Abalos Therapeutics's top competitors. Agenus was founded in 1994, and its headquarters is in Lexington, Massachusetts. Agenus competes in the Biotechnology field. Agenus has 293 more employees than Abalos Therapeutics.

NexImmune is Abalos Therapeutics's #2 rival. NexImmune was founded in 2011 in Gaithersburg, Maryland. NexImmune operates in the Biotechnology industry. NexImmune generates $17M more revenue than Abalos Therapeutics.

bluebird bio is a top competitor of Abalos Therapeutics. bluebird bio is a Public company that was founded in Cambridge, Massachusetts in 1992. bluebird bio is in the Biotechnology industry. bluebird bio has 1,136 more employees vs. Abalos Therapeutics.

Weigh-in!

Help the Owler community know more

Growth Score - 1/1

Is $5M a good estimate for Abalos Therapeutics's revenue?

Acquisitions

No recent acquisitions found related to Abalos Therapeutics

Abalos Therapeutics Funding History

$13M

Since Abalos Therapeutics was founded in 2019, it has participated in 1 round of funding. In total Abalos Therapeutics has raised $13.0M. Abalos Therapeutics' funding round was on Oct 2019 for a total of $13.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Series A
Oct 2019
$13M

Boehringer Ingelheim Venture Fund (BIVF)

Since Abalos Therapeutics was founded in 2019, it has participated in 1 round of funding. In total Abalos Therapeutics has raised $13.0M. Abalos Therapeutics' funding round was on Oct 2019 for a total of $13.0M

Investments

No recent investments found related to Abalos Therapeutics

Abalos Therapeutics News

Social Media

Headquarters

Alfredstrasse 81

Essen, Baden-Württemberg45130

49-201-565-78700

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Abalos Therapeutics is a biotechnology company that develops drugs for tumors and cancer. Abalos Therapeutics was founded in 2019. Abalos Therapeutics' headquarters is located in Essen, Baden-Württemberg, DE 45130. It has raised 13.0M in 1 round. The ...

CEO

Abalos Therapeutics's CEO, Marcus Kostka, currently has an approval rating of 90%. Abalos Therapeutics's primary competitors are Agenus, NexImmune & bluebird bio.

Website

abalos-tx.com

Frequently Asked Questions about Abalos Therapeutics

  1. When was Abalos Therapeutics founded?

    Abalos Therapeutics was founded in 2019
  2. Who is Abalos Therapeutics's CEO?

    Abalos Therapeutics's CEO is Marcus Kostka
  3. How much revenue does Abalos Therapeutics generate?

    Abalos Therapeutics generates $5M in revenue
  4. How much funding does Abalos Therapeutics have?

    Abalos Therapeutics has historically raised $13M in funding
  1. Where is Abalos Therapeutics's headquarters?

    Abalos Therapeutics's headquarters is in Essen Baden-Württemberg, DE
  2. How many employees does Abalos Therapeutics have?

    Abalos Therapeutics has 35 employees
  3. What sector does Abalos Therapeutics operate in?

    Abalos Therapeutics is in Pharmaceuticals
  4. Who are Abalos Therapeutics's competitors?

    Abalos Therapeutics's top competitors are Agenus, NexImmune, bluebird bio